Moderna Therapeutics Sucks Up Another $110 Million To Make Messenger RNA Drugs
Published: Nov 20, 2013
Moderna Therapeutics doesn’t need cash to keep the doors open, like many biotech startups. It just went out and raised a ton of dough, anyway.
The Cambridge, MA-based biotech startup, which is attempting to make injectable messenger RNA molecules that trigger production of protein drugs in the body, has raised a whopping $110 million in new equity financing.
Help employers find you! Check out all the jobs and post your resume.